|
By Anke A.
Ehrhardt, Ph.D.
When one thinks about the global HIV/AIDS epidemic,
the Middle East and North Africa (MENA) region may not
be the first part of the world to come to mind. The
devastation caused by AIDS in Sub-Saharan Africa, as
well as in other regions including Southeast Asia and
the Caribbean, has rightly focused much attention on
those afflicted areas. But HIV is, of course,
a pandemic – found in every region and, indeed, every
country in the world, and as we know only too well, the
epidemic can spiral out of control unless proactive
steps are taken to promote effective HIV prevention. The
MENA region, as an area of comparatively low seroprevalence, thus offers an important opportunity to
try to get ahead of the virus. The HIV Center and our
collaborators at the UCLA Program in Global Health
(Director: Thomas J. Coates, Ph.D.) have undertaken a wide range of activities
and initiatives in this region, a topic which is the
subject of the lead
story in this issue of the HIV Center
E-Newsletter.
Despite important advances in the roll-out and
scale-up of access to HIV treatments in the developed
world, we will never be able to “treat ourselves out of
the epidemic.” Given present technologies, those who
acquire HIV are infected for life and thus able to
further transmit the virus. With no viable vaccine on
the horizon, prevention will remain key to halting the
spread of HIV. In most of the world, the epidemic is
predominantly transmitted through sexual contact. While
intravenous drug use plays an important role in many
regions and may be the critical mode of transmission in
the beginning of an epidemic, typically it overlaps
with increasing sexual transmission. In other words, HIV
positive IDUs may not only infect others through needle
sharing but also through sexual contact with non-IDUs
and other uninfected IDUs.
Thus, prevention of sexual transmission is crucial,
yet often impeded by a host of behavioral factors, such
as low condom use and multiple concurrent partnerships,
in interplay with social factors including age mixing
between older men and younger women or girls, sexual
violence, and economic dependence. Our
unfolding work in the MENA region seeks to address these
factors by maximizing knowledge gained through research
into behavioral interventions.
Over the past 25 years, behavioral science research
has established the efficacy of such interventions to
reduce HIV risk behavior and disease incidence. A large
number of well-designed, controlled, randomized trials
have demonstrated substantial efficacy, including among
women, [continued ...] |
adolescents, drug users, men who have sex with
men, and other vulnerable populations; these have
employed individual, couple, small-group, and
community-level interventions. Behavioral interventions
are critical components of any strategic plan,
but they are labor-intensive and are not sufficient by
themselves to change the course of the epidemic. While
we know what prevention strategies work, there remain
huge barriers to implementation of a comprehensive and
sustained effective efforts on prevention. Thus we will
increasingly also need to turn to structural
interventions, which are defined as programs or
policies that change the environments in which risk
behaviors occur, without necessarily attempting to
directly change knowledge, attitudes, or social
interaction patterns of the persons at risk.
"Despite important
advances in the roll-out and scale-up of access to
HIV treatments in the developing world, we will never
be able to 'treat ourselves out of the epidemic.'
With no viable vaccine on the horizon, prevention
will remain key to halting the spread of HIV."
The most dramatic success has been achieved in those
countries that reacted quickly or mobilized the entire
society, when the epidemic reached a critical level.
Unfortunately, there are only a few success stories
which can be reviewed. However, their strategies are
impressive and quite consistent and, thus, can and
should teach other nations important lessons. The
decline in Uganda was the earliest reported in HIV
prevalence for women between 15 to 49 years of age,
declining from 30% to 10%. Uganda had initiated a
comprehensive HIV program on ABC -- abstinence, be
faithful, and condom information and distribution.
Sexual changes were observed in delaying first sexual
intercourse, having fewer sexual partners, and adopting condom
use, particularly with casual partners. More recently,
similar results have been reported in parts of Kenya and
Zimbabwe. Thailand employed a different policy by
focusing on brothels and making condom use mandatory for
male customers and sex workers.
Fortunately, the Middle East and North Africa has not
experienced an AIDS epidemic on the scale of that found
in Uganda, Kenya, or Thailand. But it is for precisely
that reason that the unfolding research agenda there is
so promising. Of course, researchers with the HIV
Center -- or indeed anywhere outside the MENA
region itself -- can only have a limited impact. The
crucial impetus must, ultimately, come from within those
societies, and thus a great deal of our work has been to
help build connections and collaborations with
researchers from throughout the region. To learn more
about the vision for HIV prevention in the Middle East
and North Africa from an insider’s perspective, we
invite you to read the article in this issue by our
Cairo-based colleague Dr. Sherine Shawky entitled “An
HIV Center in the Middle East and North Africa?” |